Literature DB >> 14000228

The use of ethamivan in the treatment of barbiturate poisoning.

P J WHEELDON, A W PERRY.   

Abstract

Ethamivan was used as a respiratory analeptic in the treatment of nine cases of severe barbiturate poisoning. Initial intravenous injections of 100 to 150 mg. of ethamivan increased the depth of respirations within a minute. Prolonged respiratory stimulation was achieved by a continuous intravenous infusion of 500 to 3000 mg. of ethamivan per litre of fluid. If hypotension occurred, an intravenous drip of noradrenaline was used; fluid overloading was avoided by adjusting the concentrations of drugs given, so that no more than a total of 125 c.c. of fluid per hour was administered. The chief side effect of overdosage of ethamivan was muscular twitching. This did not prove to be a problem and was of some value in determining the amount of drug given. The nine patients survived. It was concluded that ethamivan is a useful agent in the treatment of barbiturate poisoning.

Entities:  

Keywords:  ANALEPTICS; BARBITURATE TOXICOLOGY

Mesh:

Substances:

Year:  1963        PMID: 14000228      PMCID: PMC1921664     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  Vanillic diethylamide in the management of acute respiratory insufficiency: a preliminary report.

Authors:  M ARONOVITCH; L M KAHANA; J F MEAKINS; R E PLACE; R LAING
Journal:  Can Med Assoc J       Date:  1961-10-14       Impact factor: 8.262

2.  Use of antagonists in drug-induced coma.

Authors:  J ADRIANI; P DRAKE; J ARENS
Journal:  JAMA       Date:  1962-03-10       Impact factor: 56.272

3.  Pharmacologic effects of intravenous vanillic acid diethylamide in man.

Authors:  M J MILLER; B M HAND; J A CRELLIN
Journal:  Clin Pharmacol Ther       Date:  1961 Sep-Oct       Impact factor: 6.875

4.  Some trails with vanillic diethylamide: a new analeptic.

Authors:  A ROMAGNOLI; M J DIAMOND
Journal:  Can Anaesth Soc J       Date:  1961-11
  4 in total
  1 in total

1.  EFFECTS OF ETHAMIVAN IN PATIENTS WITH CHRONIC RESPIRATORY DISEASE.

Authors:  B J SPROULE; R L JANS; H BREITKREUTZ; W MAHON
Journal:  Can Med Assoc J       Date:  1964-12-05       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.